Dimitra Tsavachidou
Abramson Family Cancer Research Institute
University of Pennsylvania
Philadelphia
Pennsylvania 19104
USA
Name/email consistency: high
- SPRY2 is an inhibitor of the ras/extracellular signal-regulated kinase pathway in melanocytes and melanoma cells with wild-type BRAF but not with the V599E mutant. Tsavachidou, D., Coleman, M.L., Athanasiadis, G., Li, S., Licht, J.D., Olson, M.F., Weber, B.L. Cancer Res. (2004)